• Mashup Score: 4

    If you missed #CGAIGC22 or simply want to watch the presentation by Megha Ranganathan, MS, CGC again – Case Report: Non-Binary Patient with a Germline {CDH1} Pathogenic Variant: Counseling and Clinical Considerations. Despite a growing population of non-binary patients, there is limited research on genetic counseling considerations in gender diverse populations with hereditary cancer…

    Tweet Tweets with this article
    • RT @CGAIGC: 📢New resource available ❗️https://t.co/qvX5bnj281 ➡️@meghar111 #CGAIGC22 case report: Non-Binary Patient with a Germline {CDH1…

  • Mashup Score: 1

    PURPOSE Whether germline multigene panel testing (MGPT) should be performed in all individuals with colorectal cancer (CRC) remains uncertain. Therefore, we aimed to determine the yield and potential clinical impact of MGPT across a large, diverse CRC cohort. METHODS This was a retrospective cohort study of adults with CRC who underwent MGPT of > 10 genes at a commercial laboratory between March…

    Tweet Tweets with this article
    • Publication in @JCOPO_ASCO: Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With #ColorectalCancer https://t.co/m4YcDVc0Qk #CGAIGC22 https://t.co/naT7Hw64o7 https://t.co/1DiZi5unEj